Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) FCF Margin % : -4.96% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tianjin Pharmaceutical Da Ren Tang Group's Free Cash Flow for the three months ended in Mar. 2024 was ¥-103 Mil. Tianjin Pharmaceutical Da Ren Tang Group's Revenue for the three months ended in Mar. 2024 was ¥2,086 Mil. Therefore, Tianjin Pharmaceutical Da Ren Tang Group's FCF Margin % for the quarter that ended in Mar. 2024 was -4.96%.

As of today, Tianjin Pharmaceutical Da Ren Tang Group's current FCF Yield % is 1.24%.

The historical rank and industry rank for Tianjin Pharmaceutical Da Ren Tang Group's FCF Margin % or its related term are showing as below:

SHSE:600329' s FCF Margin % Range Over the Past 10 Years
Min: -2.08 Med: 4.47 Max: 10.07
Current: 3.7

During the past 13 years, the highest FCF Margin % of Tianjin Pharmaceutical Da Ren Tang Group was 10.07%. The lowest was -2.08%. And the median was 4.47%.

SHSE:600329's FCF Margin % is ranked better than
60.95% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.2 vs SHSE:600329: 3.70

Tianjin Pharmaceutical Da Ren Tang Group FCF Margin % Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group FCF Margin % Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

4.14

7.30

10.07

6.90

6.66

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															6.61	-4.40	-3.51	22.64	-4.96

Competitive Comparison of Tianjin Pharmaceutical Da Ren Tang Group's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tianjin Pharmaceutical Da Ren Tang Group's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's FCF Margin % falls into.

Tianjin Pharmaceutical Da Ren Tang Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tianjin Pharmaceutical Da Ren Tang Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	547.56	/	8222.312
	=	6.66 %

Tianjin Pharmaceutical Da Ren Tang Group's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-103.498	/	2085.588
	=	-4.96 %

Tianjin Pharmaceutical Da Ren Tang Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » FCF Margin %

Traded in Other Exchanges

T14:Singapore

Address

No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193

Website

http://www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines